Skip to main content
ALHC
NASDAQ Finance

CEO John Kao Appointed Chairman; New COO and President MSO Named

Analysis by Arik Shkolnikov
Sentiment info
Neutral
Importance info
7
Price
$18.3
Mkt Cap
$3.8B
52W Low
$11.625
52W High
$23.87
Market data snapshot near publication time

summarizeSummary

Alignment Healthcare announced CEO John Kao's appointment as Chairman of the Board, alongside new appointments for Chief Operations Officer and President of Management Services Organization, signaling a strategic focus on scaling for growth.


check_boxKey Events

  • CEO Appointed Chairman

    John Kao, the current Chief Executive Officer, has been appointed to serve as Chair of the Board, succeeding Joseph Konowiecki.

  • New Operational Leadership

    Shane Hochradel was appointed Chief Operations Officer and Mark Kent was appointed President – Management Services Organization, strengthening the company's operational structure.

  • Former Chairman's New Role

    Joseph Konowiecki, the former Chairman, will now serve as Vice Chair of the Board and Executive Vice President – Corporate Affairs.


auto_awesomeAnalysis

Alignment Healthcare has officially announced significant leadership changes aimed at strengthening its executive team for long-term growth. CEO John Kao now also serves as Chairman of the Board, consolidating leadership. The appointment of a new Chief Operations Officer and President of Management Services Organization indicates a focus on scaling operations.

At the time of this filing, ALHC was trading at $18.30 on NASDAQ in the Finance sector, with a market capitalization of approximately $3.8B. The 52-week trading range was $11.63 to $23.87. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ALHC - Latest Insights

ALHC
May 12, 2026, 4:34 PM EDT
Filing Type: DEFA14A
Importance Score:
7
ALHC
May 12, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
8
ALHC
May 12, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
7
ALHC
Apr 30, 2026, 4:01 PM EDT
Source: Reuters
Importance Score:
8
ALHC
Apr 30, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
ALHC
Apr 24, 2026, 10:52 AM EDT
Filing Type: DEF 14A
Importance Score:
7
ALHC
Mar 04, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
ALHC
Mar 03, 2026, 3:13 PM EST
Filing Type: 424B7
Importance Score:
7
ALHC
Mar 02, 2026, 9:05 PM EST
Source: GlobeNewswire
Importance Score:
7
ALHC
Mar 02, 2026, 4:49 PM EST
Source: Reuters
Importance Score:
7